Introduction:
This quiz set on accelerated stability testing follows ICH and WHO principles and focuses on practical data interpretation for M.Pharm students. It covers accelerated study design, recommended conditions, statistical methods, degradation kinetics, Arrhenius extrapolation, photostability, forced degradation, and regulatory considerations. Questions emphasize how to interpret accelerated results for shelf-life estimation, when accelerated data are acceptable for extrapolation, and how to recognize changes in degradation mechanisms. These MCQs will help you consolidate concepts needed for designing studies, analyzing rate constants, and applying guidelines during product development and regulatory submissions.
Q1. What is the standard accelerated stability condition most commonly recommended by ICH for drug products in many climatic zones?
- 25°C / 60% RH
- 30°C / 65% RH
- 40°C / 75% RH
- 5°C / 60% RH
Correct Answer: 40°C / 75% RH
Q2. According to ICH Q1A(R2), how long is a typical accelerated stability study performed to support initial evaluation?
- 1 month
- 3 months
- 6 months
- 24 months
Correct Answer: 6 months
Q3. Which statement best describes the Arrhenius approach used in accelerated stability analysis?
- Plot percent remaining versus time to get activation energy directly
- Plot ln(k) versus 1/T to derive the activation energy from slope
- Use humidity alone to calculate shelf-life
- Use photostability data to estimate thermal degradation rates
Correct Answer: Plot ln(k) versus 1/T to derive the activation energy from slope
Q4. For a drug that follows first-order degradation, which formula gives the time to 90% label claim (t90)?
- t90 = 0.1053 / k
- t90 = (0.9 × C0) / k
- t90 = ln(2) / k
- t90 = k / 0.1053
Correct Answer: t90 = 0.1053 / k
Q5. Which condition must be met before using accelerated data to extrapolate shelf-life to long-term conditions?
- Accelerated study must always show no degradation
- Degradation mechanism and pathway must be the same at accelerated and real-time conditions
- Accelerated temperature must be lower than long-term temperature
- Only a single batch is required for extrapolation
Correct Answer: Degradation mechanism and pathway must be the same at accelerated and real-time conditions
Q6. Which ICH guideline specifically addresses photostability testing requirements?
- Q1A(R2)
- Q1B
- Q1E
- Q3B
Correct Answer: Q1B
Q7. ICH photostability testing requires exposure to what minimum light energy for visible light?
- 1.2 million lux hours
- 200 lux hours
- 100,000 lux hours
- 10 million lux hours
Correct Answer: 1.2 million lux hours
Q8. Which of the following describes “forced degradation” studies?
- Long-term stability testing under recommended storage conditions
- Stress testing under exaggerated conditions to identify degradation pathways
- Photostability testing only
- Microbiological challenge testing
Correct Answer: Stress testing under exaggerated conditions to identify degradation pathways
Q9. When using Arrhenius extrapolation, what does the slope of the ln(k) vs 1/T plot represent?
- Rate constant at standard temperature
- Activation energy divided by the gas constant with a negative sign
- Half-life value
- Intercept for zero-order kinetics
Correct Answer: Activation energy divided by the gas constant with a negative sign
Q10. Which kinetic order is commonly assumed when percent potency loss is proportional to concentration?
- Zero-order kinetics
- First-order kinetics
- Second-order kinetics
- Mixed-order kinetics only
Correct Answer: First-order kinetics
Q11. In stability data analysis, why is it important to check whether accelerated data show new degradation products not seen in real-time studies?
- New degradants indicate method sensitivity is insufficient
- New degradants may indicate a change in degradation mechanism and make extrapolation invalid
- New degradants always mean the product is unsafe
- New degradants are ignored for regulatory submissions
Correct Answer: New degradants may indicate a change in degradation mechanism and make extrapolation invalid
Q12. What is the primary purpose of bracketing and matrixing designs in accelerated stability testing?
- To reduce the number of analytical methods required
- To allow reduced testing by selecting representative strengths, presentations or storage conditions
- To increase the sample size for statistical power
- To determine microbiological stability
Correct Answer: To allow reduced testing by selecting representative strengths, presentations or storage conditions
Q13. Which statistical method is typically used to estimate shelf-life and provide confidence intervals from stability data?
- Non-linear regression with bootstrapping only
- Simple arithmetic averaging of measurements
- Linear regression of ln(concentration) (for first-order) and calculation of confidence limits
- ANOVA without regression
Correct Answer: Linear regression of ln(concentration) (for first-order) and calculation of confidence limits
Q14. A product shows linear ln(concentration) vs time at both 25°C and 40°C with the same degradation products. Which is a valid next step to estimate shelf-life at 25°C?
- Use the 40°C k value directly as the 25°C shelf-life
- Apply Arrhenius extrapolation using k values at multiple temperatures to determine k at 25°C
- Assume shelf-life is twice that at 40°C
- Ignore 40°C data and use only photostability results
Correct Answer: Apply Arrhenius extrapolation using k values at multiple temperatures to determine k at 25°C
Q15. What is the ICH/WHO recommended action if accelerated conditions produce irreversible physical changes (e.g., melting, phase separation) not seen at long-term conditions?
- Use accelerated data for shelf-life without modification
- Do not use accelerated data for extrapolation and investigate cause and appropriate packaging or formulation changes
- Discard long-term data and rely solely on accelerated results
- Assume packaging is adequate and proceed to market
Correct Answer: Do not use accelerated data for extrapolation and investigate cause and appropriate packaging or formulation changes
Q16. Which of the following is a WHO-specific consideration for stability testing of multi-source (generic) products?
- WHO requires only accelerated testing and never real-time studies
- WHO emphasizes testing relevant climatic zones and critical excipient equivalence for generics
- WHO does not recognize ICH guidelines
- WHO requires photostability only for injectables
Correct Answer: WHO emphasizes testing relevant climatic zones and critical excipient equivalence for generics
Q17. The Q10 rule is sometimes used for rough estimation. What does Q10 represent?
- The percent RH increase per 10°C
- The factor by which the reaction rate increases when temperature increases by 10°C
- The number of degradation products formed per 10°C
- The shelf-life in months at 10°C
Correct Answer: The factor by which the reaction rate increases when temperature increases by 10°C
Q18. In accelerated stability studies, why is container-closure system evaluation essential?
- Because container-closure has no impact on stability
- Because container-closure can interact with product or affect moisture ingress resulting in altered degradation
- Only aesthetics are assessed by container-closure testing
- Container-closure testing is only needed for clinical trials
Correct Answer: Because container-closure can interact with product or affect moisture ingress resulting in altered degradation
Q19. Which outcome from an accelerated study would most likely invalidate simple Arrhenius extrapolation to predict shelf-life?
- Consistent first-order kinetics at each temperature with identical degradants
- Non-linear Arrhenius plot indicating a change in activation energy across temperatures
- Parallel ln(k) plots across stresses
- Reversible physical changes that revert at room temperature
Correct Answer: Non-linear Arrhenius plot indicating a change in activation energy across temperatures
Q20. When analyzing accelerated stability results statistically, what is the regulatory-recommended confidence level often used for shelf-life estimation?
- 50% confidence interval
- 80% confidence interval
- 90% confidence interval
- 95% confidence interval
Correct Answer: 95% confidence interval

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

